SEC Form 3 · accession 0001567619-18-003226
Gritstone Oncology, Inc. · GRTS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew R Allen
Officer — President and CEO · Director
Period of report
Sep 27, 2018
Accepted (ET)
Sep 27, 2018 · 5:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001656634
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 1,449,275 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $9.60 | holding | — | — | — | Oct 27, 2018 | Aug 6, 2028 | Common Stock | 142,028 | — | D |
Explanation of responses
- F1The shares are held in the name of the Reporting Person's revocable trust of which the Reporting Person is a co-trustee. The Reporting person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
- F2The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on September 27, 2018.